📋 Product Overview Table
| 🌟 Parameter | 🔍 Details |
|---|---|
| 🧬 Active Ingredient | Pramipexole (Available in 0.25 mg, 0.5 mg, 1 mg) |
| 💊 Indication | Parkinson’s disease, Restless Legs Syndrome (RLS) |
| 🇺🇸 US Brand Equivalent | Mirapex |
| 🏭 Manufacturer | Sun Pharmaceutical Industries Ltd. |
| 📦 Packaging | 10 tablets per strip |
| 💪 Strength | 0.25 mg, 0.5 mg, 1 mg |
| 🚚 Delivery Time | 6–15 days (Worldwide including USA, UK, Australia) |
🧬 What is Pramipex (Pramipexole)?
Pramipex is a dopamine agonist used primarily in the treatment of Parkinson’s disease and Restless Legs Syndrome (RLS). Manufactured by Sun Pharmaceutical Industries Ltd., this medication helps restore dopamine activity in the brain, which is typically reduced in Parkinson’s patients.
Pramipexole, the active ingredient in Pramipex, mimics the action of dopamine—a key neurotransmitter responsible for regulating movement and coordination. It reduces symptoms such as tremors, stiffness, and slowness of movement. For RLS, it relieves the unpleasant sensations and urge to move the legs, particularly during rest or sleep.
Pramipex is available in three strengths—0.25 mg, 0.5 mg, and 1 mg—allowing personalized dosing based on patient needs. It is often used as monotherapy in early stages of Parkinson’s, or in combination with Levodopa in more advanced stages.
🎬 Educational Video Placeholder
🩺 Doctor’s Expert Commentary
Dr. Arjun Mehta, Neurologist:
“Pramipexole has become a first-line therapy for Parkinson’s, especially in younger patients. It delays the need for Levodopa and effectively controls RLS. Pramipex by Sun Pharma is both reliable and cost-effective.”
💉 Dosage & Administration
| 📄 Condition | 💊 Starting Dosage | ✏️ Notes |
|---|---|---|
| Parkinson’s (Monotherapy) | 0.125–0.25 mg once daily | Gradually increase to 1.5 mg/day |
| Parkinson’s (with Levodopa) | 0.25 mg 2–3 times per day | Adjust based on symptoms |
| Restless Legs Syndrome (RLS) | 0.125 mg once daily (evening) | Max dose 0.5 mg/day, 2–3 hours before bedtime |
Dosing should be titrated under medical supervision. Abrupt discontinuation may cause withdrawal symptoms.
⚠️ Side Effects, Warnings & Storage
- Common Side Effects: Dizziness, nausea, sleepiness, dry mouth, hallucinations
- Serious Risks: Sudden sleep attacks, compulsive behaviors, orthostatic hypotension
- Cautions: Use with care in kidney impairment, avoid alcohol, do not operate machinery
- Storage: Store below 25°C in a dry place, away from sunlight
🌍 Global Availability
| 🌐 Country | 🚚 Shipping Available | 💵 Estimated Price (10 tablets) | 📜 Prescription Required |
|---|---|---|---|
| 🇺🇸 USA | ✅ Yes | $12–18 | Yes |
| 🇬🇧 UK | ✅ Yes | £9–13 | Yes |
| 🇦🇺 Australia | ✅ Yes | AUD 16–22 | Yes |
🔗 Related Indian Alternatives (Same Therapeutic Category)
| 💊 Product Name | 🏭 Manufacturer | 🔗 Link |
|---|---|---|
| Entacom 200 mg | Intas Pharmaceuticals | Entacom 200 mg |
| Syndopa CR 250 mg | Sun Pharma | Syndopa CR 250 mg |
| Syncapone 150 mg | Sun Pharma | Syncapone 150 mg |
| Syndopa Plus 125 mg | Sun Pharma | Syndopa Plus 125 mg |
| Rasagiline 1 mg | Cipla Ltd | Rasagiline 1 mg |
📚 Trusted Medical References
- Drugs.com – Pramipexole Overview
- NHS – Parkinson’s Disease Treatments
- Sun Pharmaceutical Official Site
⚠️ Medical Disclaimer
This content is for informational purposes only. Always consult a healthcare provider before starting any new treatment.




